Global Women Health Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 121 pages | ID: G579DE4A400EN
GlobalInfoResearch

Abstracts

Women's experience of health and disease differ from those of men, due to unique biological, social and behavioural conditions. Biological differences vary all the way from phenotype to the cellular, and manifest unique risks for the development of ill health.

Scope of the Report:

Rise in cases of infertility and increasing incidences of chronic disorders among women are seen as the key forces driving the growth of the global market.

The global Women Health Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Women Health Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Women Health Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Women Health Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers

• Novartis
• Abbott
• Pfizer
• Eli Lilly
• Bayer
• Merck
• Roche
• Novo Nordisk
• Oasmia
• Sanofi
• Takeda
• Allergan

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Menopause
• Endometriosis
• Postmenopausal osteoporosis
• Breast cancer
• Polycystic ovary syndrome
• Infertility
• Gynecological cancer

Market Segment by Applications, can be divided into

• Diagnostic and imaging centers
• Hospitals and clinics
• Home care

Contents

1 WOMEN HEALTH THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Women Health Therapeutics
1.2 Classification of Women Health Therapeutics by Types
  1.2.1 Global Women Health Therapeutics Revenue Comparison by Types (2017-2023)
  1.2.2 Global Women Health Therapeutics Revenue Market Share by Types in 2017
  1.2.3 Menopause
  1.2.4 Endometriosis
  1.2.5 Postmenopausal osteoporosis
  1.2.6 Breast cancer
  1.2.7 Polycystic ovary syndrome
  1.2.8 Infertility
  1.2.9 Gynecological cancer
1.3 Global Women Health Therapeutics Market by Application
  1.3.1 Global Women Health Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Diagnostic and imaging centers
  1.3.3 Hospitals and clinics
  1.3.4 Home care
1.4 Global Women Health Therapeutics Market by Regions
  1.4.1 Global Women Health Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Women Health Therapeutics Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Women Health Therapeutics Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Women Health Therapeutics Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Women Health Therapeutics Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Women Health Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Women Health Therapeutics (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Novartis
  2.1.1 Business Overview
  2.1.2 Women Health Therapeutics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Novartis Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott
  2.2.1 Business Overview
  2.2.2 Women Health Therapeutics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Abbott Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
  2.3.1 Business Overview
  2.3.2 Women Health Therapeutics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Pfizer Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
  2.4.1 Business Overview
  2.4.2 Women Health Therapeutics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Eli Lilly Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bayer
  2.5.1 Business Overview
  2.5.2 Women Health Therapeutics Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Bayer Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck
  2.6.1 Business Overview
  2.6.2 Women Health Therapeutics Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Merck Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Roche
  2.7.1 Business Overview
  2.7.2 Women Health Therapeutics Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Roche Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novo Nordisk
  2.8.1 Business Overview
  2.8.2 Women Health Therapeutics Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Novo Nordisk Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Oasmia
  2.9.1 Business Overview
  2.9.2 Women Health Therapeutics Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Oasmia Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sanofi
  2.10.1 Business Overview
  2.10.2 Women Health Therapeutics Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Sanofi Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.11 Takeda
  2.11.1 Business Overview
  2.11.2 Women Health Therapeutics Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Takeda Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.12 Allergan
  2.12.1 Business Overview
  2.12.2 Women Health Therapeutics Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 Allergan Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL WOMEN HEALTH THERAPEUTICS MARKET COMPETITION, BY PLAYERS

3.1 Global Women Health Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Women Health Therapeutics Players Market Share
  3.2.2 Top 10 Women Health Therapeutics Players Market Share
3.3 Market Competition Trend

4 GLOBAL WOMEN HEALTH THERAPEUTICS MARKET SIZE BY REGIONS

4.1 Global Women Health Therapeutics Revenue and Market Share by Regions
4.2 North America Women Health Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Women Health Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Women Health Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Women Health Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Women Health Therapeutics Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA WOMEN HEALTH THERAPEUTICS REVENUE BY COUNTRIES

5.1 North America Women Health Therapeutics Revenue by Countries (2013-2018)
5.2 USA Women Health Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Women Health Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Women Health Therapeutics Revenue and Growth Rate (2013-2018)

6 EUROPE WOMEN HEALTH THERAPEUTICS REVENUE BY COUNTRIES

6.1 Europe Women Health Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Women Health Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Women Health Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Women Health Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Women Health Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Women Health Therapeutics Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC WOMEN HEALTH THERAPEUTICS REVENUE BY COUNTRIES

7.1 Asia-Pacific Women Health Therapeutics Revenue by Countries (2013-2018)
7.2 China Women Health Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Women Health Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Women Health Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Women Health Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Women Health Therapeutics Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA WOMEN HEALTH THERAPEUTICS REVENUE BY COUNTRIES

8.1 South America Women Health Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Women Health Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Women Health Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Women Health Therapeutics Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE WOMEN HEALTH THERAPEUTICS BY COUNTRIES

9.1 Middle East and Africa Women Health Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Women Health Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Women Health Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Women Health Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Women Health Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Women Health Therapeutics Revenue and Growth Rate (2013-2018)

10 GLOBAL WOMEN HEALTH THERAPEUTICS MARKET SEGMENT BY TYPE

10.1 Global Women Health Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Women Health Therapeutics Market Forecast by Type (2018-2023)
10.3 Menopause Revenue Growth Rate (2013-2023)
10.4 Endometriosis Revenue Growth Rate (2013-2023)
10.5 Postmenopausal osteoporosis Revenue Growth Rate (2013-2023)
10.6 Breast cancer Revenue Growth Rate (2013-2023)
10.7 Polycystic ovary syndrome Revenue Growth Rate (2013-2023)
10.8 Infertility Revenue Growth Rate (2013-2023)
10.9 Gynecological cancer Revenue Growth Rate (2013-2023)

11 GLOBAL WOMEN HEALTH THERAPEUTICS MARKET SEGMENT BY APPLICATION

11.1 Global Women Health Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Women Health Therapeutics Market Forecast by Application (2018-2023)
11.3 Diagnostic and imaging centers Revenue Growth (2013-2018)
11.4 Hospitals and clinics Revenue Growth (2013-2018)
11.5 Home care Revenue Growth (2013-2018)

12 GLOBAL WOMEN HEALTH THERAPEUTICS MARKET SIZE FORECAST (2018-2023)

12.1 Global Women Health Therapeutics Market Size Forecast (2018-2023)
12.2 Global Women Health Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Women Health Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Women Health Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Women Health Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Women Health Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Women Health Therapeutics Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Women Health Therapeutics Picture
Table Product Specifications of Women Health Therapeutics
Table Global Women Health Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Women Health Therapeutics Revenue Market Share by Types in 2017
Figure Menopause Picture
Figure Endometriosis Picture
Figure Postmenopausal osteoporosis Picture
Figure Breast cancer Picture
Figure Polycystic ovary syndrome Picture
Figure Infertility Picture
Figure Gynecological cancer Picture
Table Global Women Health Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure Women Health Therapeutics Revenue Market Share by Applications in 2017
Figure Diagnostic and imaging centers Picture
Figure Hospitals and clinics Picture
Figure Home care Picture
Table Global Market Women Health Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Women Health Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Women Health Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Women Health Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Women Health Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Women Health Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Women Health Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Women Health Therapeutics Type and Applications
Table Novartis Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Women Health Therapeutics Type and Applications
Table Abbott Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Women Health Therapeutics Type and Applications
Table Pfizer Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Women Health Therapeutics Type and Applications
Table Eli Lilly Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Women Health Therapeutics Type and Applications
Table Bayer Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Women Health Therapeutics Type and Applications
Table Merck Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Women Health Therapeutics Type and Applications
Table Roche Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Women Health Therapeutics Type and Applications
Table Novo Nordisk Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Oasmia Basic Information, Manufacturing Base and Competitors
Table Oasmia Women Health Therapeutics Type and Applications
Table Oasmia Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Women Health Therapeutics Type and Applications
Table Sanofi Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Women Health Therapeutics Type and Applications
Table Takeda Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Women Health Therapeutics Type and Applications
Table Allergan Women Health Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Women Health Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global Women Health Therapeutics Revenue Share by Players (2013-2018)
Figure Global Women Health Therapeutics Revenue Share by Players in 2016
Figure Global Women Health Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Women Health Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Women Health Therapeutics Revenue Market Share in 2017
Figure Global Women Health Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Women Health Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global Women Health Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Women Health Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Women Health Therapeutics Revenue Market Share by Regions in 2017
Figure North America Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Women Health Therapeutics Revenue by Countries (2013-2018)
Table North America Women Health Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Women Health Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Women Health Therapeutics Revenue Market Share by Countries in 2017
Figure USA Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Women Health Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Women Health Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Women Health Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Women Health Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Women Health Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Women Health Therapeutics Revenue Market Share by Countries in 2017
Figure China Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Women Health Therapeutics Revenue by Countries (2013-2018)
Table South America Women Health Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Women Health Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Women Health Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Women Health Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Women Health Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Women Health Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Women Health Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Women Health Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Women Health Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Women Health Therapeutics Revenue Share by Type (2013-2018)
Figure Global Women Health Therapeutics Revenue Share by Type (2013-2018)
Figure Global Women Health Therapeutics Revenue Share by Type in 2017
Table Global Women Health Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Women Health Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global Menopause Revenue Growth Rate (2013-2018)
Figure Global Endometriosis Revenue Growth Rate (2013-2018)
Figure Global Postmenopausal osteoporosis Revenue Growth Rate (2013-2018)
Figure Global Breast cancer Revenue Growth Rate (2013-2018)
Figure Global Polycystic ovary syndrome Revenue Growth Rate (2013-2018)
Figure Global Infertility Revenue Growth Rate (2013-2018)
Figure Global Gynecological cancer Revenue Growth Rate (2013-2018)
Table Global Women Health Therapeutics Revenue by Application (2013-2018)
Table Global Women Health Therapeutics Revenue Share by Application (2013-2018)
Figure Global Women Health Therapeutics Revenue Share by Application (2013-2018)
Figure Global Women Health Therapeutics Revenue Share by Application in 2017
Table Global Women Health Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Women Health Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global Diagnostic and imaging centers Revenue Growth Rate (2013-2018)
Figure Global Hospitals and clinics Revenue Growth Rate (2013-2018)
Figure Global Home care Revenue Growth Rate (2013-2018)
Figure Global Women Health Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Women Health Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Women Health Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Women Health Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Women Health Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Women Health Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Women Health Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Women Health Therapeutics Revenue Market Forecast (2018-2023)